Skip to main content
Debate: First-Line Immunotherapy of MSI-H Colorectal Cancer: Single Agent vs. Combination Therapy. - Single Agent.
Thursday, September 23, 2021
2:30 PM – 2:38 PM
Neil H. Segal, MD, PhD
Memorial Sloan Kettering Cancer Center
This talk is supported by educational grants provided by Bayer HealthCare Pharmaceuticals, Inc., Pfizer
Inc. and Taiho Oncology, Inc.